Table 1 Clinicopathlogial significance of ID1 mRNA expression in gastric cancer patients

From: Bone marrow and peripheral blood expression of ID1 in human gastric carcinoma patients is a bona fide indicator of lymph node and peritoneal metastasis

 

Bone marrow

Peripheral blood

Features

Number

ID1 mRNA expression (mean±s.d.)

P -value

Number

ID1 mRNA expression (mean±s.d.)

P -value

Age

289

62.3±11.9

196

62.9±12.2

Sex (M : F)

289

190 : 99

196

131 : 65

Tumour size

  

0.01

  

0.002

5 cm

126

311±146

 

85

24.8±12.2

 

5 cm

160

795±129

 

110

64.6±10.7

 

Depth of tumour invasion a

  

0.01

  

0.004

 m, sm

90

210±171

 

62

12.9±14.2

 

 mp, ss, se, si

199

744±115

 

134

62.8±9.6

 

Venous invasion

  

0.97

  

0.007

 Positive

72

580±199

 

50

77.8±15.2

 

 Negative

188

571±123

 

128

28.9±9.5

 

Lymphatic invasion

  

0.001

  

0.02

 Positive

156

850±132

 

110

57.8±10.3

 

 Negative

104

158±162

 

68

18.2±13.1

 

Lymph node metastasis

  

0.001

  

0.02

 Positive

188

800±121

 

132

56.7±9.6

 

 Negative

79

58.7±186

 

50

12.4±15.6

 

Peritoneal dissemination b

  

0.002

  

<0.0001

 Positive

70

1102±194

 

40

119±17.1

 

 Negative

218

412±110

 

156

28.6±8.6

 
  1. aTumour invasion of mucosa (m), submucosa (sm), muscularis propria (mp), subserosa (ss), penetration of serosa (se) and invasion of adjacent strucures (si).
  2. bPeritoneal dissemination: peritoneal cytology or metastasis positive.